Arrington v. Walgreen Co.

664 F. Supp. 2d 1230, 2009 U.S. Dist. LEXIS 94285, 2009 WL 3273217
CourtDistrict Court, M.D. Florida
DecidedOctober 9, 2009
Docket8:09-mj-01300
StatusPublished
Cited by3 cases

This text of 664 F. Supp. 2d 1230 (Arrington v. Walgreen Co.) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Arrington v. Walgreen Co., 664 F. Supp. 2d 1230, 2009 U.S. Dist. LEXIS 94285, 2009 WL 3273217 (M.D. Fla. 2009).

Opinion

ORDER

GREGORY A. PRESNELL, District Judge.

This matter comes before the Court on the Motion to Dismiss (Doc. 15) filed by the Defendant, Walgreen Co. (‘Walgreens”), and the response (Doc. 16) filed by the Plaintiff, Nellie Arrington (“Arrington”), in her capacity as personal representative of the estate of Ella Church (“Church”).

I. Background

According to the allegations of the Amended Complaint (Doc. 6), which are accepted as true for purposes of resolving this motion, Church was discharged from a hospital on February 18, 2006 and given a prescription for “Bactrim DS/Septra DS.” (Doc. 6 at 2). Church took the prescription to a Walgreens pharmacy, where it was filled with a generic version of the drug, which was sulfa-based. (Doc. 6 at 2). At the time the prescription was filled, Walgreens, “through its agents and/or employees, actively knew and possessed the knowledge” that Church was allergic to sulfa-based drugs.” (Doc. 6 at 3). The drug caused a severe allergic reaction and injuries. (Doc. 6 at 3). Arrington has sued Walgreens for negligence (Count I), reckless disregard (Count II), intentional misconduct (Count III), and active fraud (Count IV).

II. Standards

Federal Rule of Civil Procedure 8(a)(2) requires “a short and plain statement of the claim showing that the pleader is entitled to relief,” so as to “give the defendant fair notice of what the ... claim is and the grounds upon which it rests.” Conley v. Gibson, 355 U.S. 41, 47, 78 S.Ct. 99, 2 L.Ed.2d 80 (1957). In ruling on a motion to dismiss for failure to state a claim under Rule 12(b)(6), this Court must view the complaint in the light most favorable to the Plaintiff. Scheuer v. Rhodes, 416 U.S. 232, 94 S.Ct. 1683, 40 L.Ed.2d 90 (1974), and must limit its consideration to the pleadings and any exhibits attached thereto. Fed. R. Civ. P. 10(c); see also GSW, Inc. v. Long County, Ga., 999 F.2d 1508, 1510 (11th Cir.1993). The Court will liberally construe the complaint’s allegations in the Plaintiffs favor. Jenkins v. McKeithen, *1232 395 U.S. 411, 421, 89 S.Ct. 1843, 23 L.Ed.2d 404 (1969). The plaintiff must provide enough factual allegations to raise a right to relief above the speculative level. Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 127 S.Ct. 1955, 1966, 167 L.Ed.2d 929 (2007). In ruling on a motion to dismiss, “conclusory allegations, unwarranted factual deductions or legal conclusions masquerading as facts will not prevent dismissal.” Davila v. Delta Air Lines, Inc., 326 F.3d 1183, 1185 (11th Cir.2003).

III. Analysis

A. Duty

Noting that Arrington has not alleged that the prescription was filled improper ly — i.e., with the wrong drug, or without a valid prescription — Walgreens seeks dismissal of all four counts on the grounds that “the sole duty owed by a pharmacy to its customer is to properly fill all lawfully presented prescriptions.” (Doc. 15 at 2). In support, Walgreens relies on a line of cases beginning with McLeod v. W.S. Merrell Company, 174 So.2d 736 (Fla.1965). According to Walgreens, McLeod stands for the proposition that a pharmacy “has no duty to refuse to supply a patient with medication for which he has a valid and lawful prescription, nor any duty to warn of any purported dangers.” (Doc. 15 at 2). However, the Defendant interprets that case much too broadly.

McLeod was a breach of warranty case, involving a plaintiff who had been harmed by one of the known side effects of a drug that had been prescribed by his doctor. The plaintiff sought to hold the pharmacist defendants liable, under a warranty theory, for their failure to warn him of the potential side effects. Id. at 738. The McLeod court held that pharmacists do not warrant the merchantability or fitness for a particular purpose of the drugs that they dispense, and that what the plaintiff was actually seeking to impose on the pharmacists was a form of liability without fault. Id. at 739. Rejecting any imposition of strict liability, the court held that a druggist who sells a prescription warrants only that “(1) he will compound the drug prescribed; (2) he has used due and proper care in filling the prescription (failure of which might also give rise to an action in negligence); (3) the proper methods were used in the compounding process; (4) the drug has not been infected with some adulterating foreign substance.” Id.

Walgreens would have this Court interpret a pharmacist’s duty to use “due and proper care in filling the prescription” as being satisfied by a robotic compliance with the instructions of the prescribing physician. In Walgreens’ view, so long as the paperwork is in order, and so long as the drug going out the door matches the drug prescribed, the pharmacist (and, by extension, Walgreens) cannot face liability. However, none of the cases cited by Walgreens go this far. And though the law in this area is far from settled, two Florida Courts of Appeal have rejected this contention.

In Dee v. Wal-Mart Stores, Inc., 878 So.2d 426, 427 (Fla. 1st DCA 2004), a doctor prescribed a painkiller containing fentanyl to a patient who had had a Cesarean section. The prescription did not have a time limit on it. Id. Four months after the prescription was written, the patient had it filled to treat an ankle injury. Id. She died in her sleep as a result of toxic overexposure to fentanyl. Id.

The plaintiff alleged that the lack of a time limit on the prescription rendered it unreasonable on its face. Id. The pre *1233 scribed painkiller was likely to be fatal if taken by a person who was not on a particular drug regimen. Id. The plaintiff asserted that a pharmacist viewing the date on the prescription would reasonably have concluded that the patient by that time was not on the proper regimen, and should have warned the patient or sought authorization from the prescribing physician before dispensing the drug. Id. at 427-28. The trial court dismissed, but the First DCA reversed, finding that the allegations stated a cause of action in negligence. Id. at 428. Relying on McLeod, the Dee court noted that a pharmacy must use due and proper care in filling a prescription. Id. at 427.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Oleckna v. Daytona Discount Pharmacy
162 So. 3d 178 (District Court of Appeal of Florida, 2015)
Lefrock v. Walgreens Co.
77 F. Supp. 3d 1199 (M.D. Florida, 2015)
Bustetter v. Armor Correctional Health Services, Inc.
919 F. Supp. 2d 1282 (M.D. Florida, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
664 F. Supp. 2d 1230, 2009 U.S. Dist. LEXIS 94285, 2009 WL 3273217, Counsel Stack Legal Research, https://law.counselstack.com/opinion/arrington-v-walgreen-co-flmd-2009.